Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897077 · ClinicalTrials.gov registry record · Phase 1
The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
A Phase 1 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01897077: Clinical Trial Phase 1 study, sponsored by Johns Hopkins University.
NCT01897077 is a Phase 1 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897077, a Phase 1 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a new method of administration of peanut sublingual immunotherapy, a dissolving peanut film, is effective.
Interventions
- DRUG Peanut Dissolving Film
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-02-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01897077
The ClinicalTrials.gov registry entry for NCT01897077 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peanut Dissolving Film is the first listed.
NCT01897077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01897077 about?
NCT01897077 is a clinical study titled "The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy". The purpose of this study is to determine if a new method of administration of peanut sublingual immunotherapy, a dissolving peanut film, is effective.
What is the current status of trial NCT01897077?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2012-11. Estimated completion is 2013-02-03.
What interventions are being tested in trial NCT01897077?
The interventions under investigation include: Peanut Dissolving Film (DRUG).
Who is sponsoring clinical trial NCT01897077?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.